Search results
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 13 hours agoNovavax entered the coronavirus vaccine market late, missing out on the biggest revenue opportunity. This disappointed investors, and the stock plummeted...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via Yahoo Finance· 1 day agoTogether with the domestic Sanofi (NASDAQ: SNY), Pfizer, AstraZeneca will together invest €1.87...
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
FX Empire via Yahoo Finance· 3 days agoThe past five days have been a rollercoaster for Novavax investors, as the share price of the...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 4 days agoBefore this development, Sanofi entered a $1bn licensing agreement with Fulcrum Therapeutics. The...
Private Advisor Group LLC Purchases 5,061 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 6 days agoPrivate Advisor Group LLC raised its position in shares of Sanofi (NASDAQ:SNY – Free Report) by 12.0% during the fourth quarter, according to its most recent disclosure with ...
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Zacks via Yahoo Finance· 4 days agoSanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with...
Sanofi to Spend $1.08 Billion to Boost Drug Production in France
The Wall Street Journal· 5 days agoSanofi said the bulk of the investment will double capacity of monoclonal antibody production, which...
Sartorius Collaborates With Sanofi to Commercialize End-to-End Platform for Downstream Process...
NewMediaWire via Yahoo Finance· 4 days agoSartorius selected as preferred partner for development and commercialization of integrated and...
Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug
Pharmaceutical Technology via Yahoo Finance· 4 days ago"Sanofi strikes $1bn deal with Fulcrum for muscular dystrophy drug" was originally created and...
Regeneron, Sanofi Get Speedy FDA Review of Dupixent in Younger CRSwNP Group
Market Watch· 5 days agoRegeneron Pharmaceuticals and Sanofi have won Food and Drug Administration priority review of their application seeking expanded approval of their blockbuster ...
